[Antinuclear factors. Demonstration and clinico-diagnostic significance].
D000974:Antibodies, Antinuclear / Q000032:analysis; D001172:Arthritis, Rheumatoid / Q000175:diagnosis; D001323:Autoantibodies / Q000032:analysis*; D001327:Autoimmune Diseases / Q000175:diagnosis*; D002908:Chronic Disease; D003882:Dermatomyositis / Q000175:diagnosis; D005455:Fluorescent Antibody Technique; D006505:Hepatitis / Q000175:diagnosis; D006801:Humans; D006827:Hydantoins / Q000009:adverse effects; D006830:Hydralazine / Q000009:adverse effects; D007538:Isoniazid / Q000009:adverse effects; D007841:Latex Fixation Tests; D008180:Lupus Erythematosus, Systemic / Q000175:diagnosis; D008722:Methods; D009504:Neutrophils; D010488:Polyarteritis Nodosa / Q000175:diagnosis; D012595:Scleroderma, Systemic / Q000175:diagnosis; D012859:Sjogren's Syndrome / Q000175:diagnosis; D013953:Thymus Neoplasms / Q000276:immunology
D000974:Antibodies, Antinuclear; D001323:Autoantibodies; D006827:Hydantoins; D006830:Hydralazine; D007538:Isoniazid
Antikernafaktoren. Nachweis und klinisch-diagnostische Bedeutung.